PORTLAND, Ore.--(BUSINESS WIRE)--AVI BioPharma, Inc. (Nasdaq:AVII), announced today that Alan P. Timmins, AVI’s president and COO, will present an overview of the company’s technology platforms and clinical drug development at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The conference will be held at the New York Palace Hotel in New York City. Timmins’ presentation will take place Monday, Nov. 5 at noon EST in the Kennedy II Room.
